160-A RANDOMISED CONTROLLED STUDY OF COGNITIVE BEHAVIOURAL THERAPY FOR HYPOCHONDRIASIS

Abstract Background: The contradiction between the burden of post-traumatic stress disorder (PTSD) and the lack of evidence-based treatments (EBTs) is common in low- and middle-income countries of Asia. The adaptation of trauma-focused cognitive behavioural therapy (TF-CBT) is helpful for meeting the needs of children in these countries. The objectives of this study were to describe the cultural adaptation process of TF-CBT and to explore the feasibility and acceptability of adapted interventions in China.Method: Based on the Map of the Adaptation Process (MAP), this study adapted the types of participants, form, content elements, length and language of TF-CBT. A total of 115 children and 8 facilitators participated in the pilot randomised controlled study. Feasibility was measured by the retention of children. Acceptability was assessed by the client satisfaction questionnaire (CSQ-8) and interviews with the children and facilitators.Result: An intervention based on TF-CBT that included 7 group sessions and 3 individual sessions was developed. The results of the pilot study showed that children had a high average retention rate (above 97%) and satisfaction (78.95%) with the intervention. Qualitative interviews showed that children and facilitators had high acceptance of the adapted intervention.Conclusion: The adapted group-based TF-CBT had good participant retention and satisfaction. It could be smoothly implemented in the Chinese school environment.Trial registration: Chinese Clinical Trial Registry, ChiCTR1800019837. Registered 2 December 2018, http://www.chictr.org.cn/showproj.aspx?proj=33479.

Download Full-text

Auricular Acupuncture and Cognitive Behavioural Therapy for Insomnia: A Randomised Controlled Study

Sleep Disorders ◽

10.1155/2016/7057282 ◽

2016 ◽

Vol 2016 ◽

pp. 1-7 ◽

Cited By ~ 5

Author(s):

L. Bergdahl ◽

J.-E. Broman ◽

A. H. Berman ◽

K. Haglund ◽

L. von Knorring ◽

...

Keyword(s):

Behavioural Therapy ◽

Controlled Study ◽

Anxiety And Depression ◽

Auricular Acupuncture ◽

Insomnia Disorder ◽

Cognitive Behavioural ◽

Randomised Controlled Study ◽

Randomised Controlled ◽

Insomnia Severity

Objective. The most effective nonpharmacological treatment for insomnia disorder is cognitive behavioural therapy-insomnia (CBT-i). However CBT-i may not suit everyone. Auricular acupuncture (AA) is a complementary treatment. Studies show that it may alleviate insomnia symptoms. The aim of this randomised controlled study was to compare treatment effects of AA with CBT-i and evaluate symptoms of insomnia severity, anxiety, and depression.Method. Fifty-nine participants, mean age 60.5 years (SD 9.4), with insomnia disorder were randomised to group treatment with AA or CBT-i. Self-report questionnaires, the Insomnia Severity Index (ISI), Dysfunctional Beliefs and Attitudes about Sleep scale (DBAS-16), Epworth Sleepiness Scale (ESS), and Hospital Anxiety and Depression scale (HAD), were collected at baseline, after treatment, and at 6-month follow-up. A series of linear mixed models were performed to examine treatment effect over time between and within the groups.Results. Significant between-group improvements were seen in favour of CBT-i in ISI after treatment and at the 6-month follow-up and in DBAS-16 after treatment. Both groups showed significant within-group postintervention improvements in ISI, and these changes were maintained six months later. The CBT-i group also showed a significant reduction in DBAS-16 after treatment and six months later.Conclusions. Compared to CBT-i, AA, as offered in this study, cannot be considered an effective stand-alone treatment for insomnia disorder. The trial is registered with ClinicalTrials.govNCT01765959.

Download Full-text

Faculty Opinions recommendation of Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13854958.15293058 ◽

2012 ◽

Author(s):

Jean Addington

Keyword(s):

Randomised Controlled Trial ◽

Cognitive Behavioural Therapy ◽

Controlled Trial ◽

Behavioural Therapy ◽

First Episode ◽

Cognitive Behavioural ◽

Randomised Controlled ◽

Early Schizophrenia

Download Full-text

Digital cognitive–behavioural therapy for insomnia compared with digital patient education about insomnia in individuals referred to secondary mental health services in Norway: protocol for a multicentre randomised controlled trial

BMJ Open ◽

10.1136/bmjopen-2021-050661 ◽

2021 ◽

Vol 11 (6) ◽

pp. e050661

Author(s):

Håvard Kallestad ◽

Simen Saksvik ◽

Øystein Vedaa ◽

Knut Langsrud ◽

Gunnar Morken ◽

...

Keyword(s):

Mental Health ◽

Randomised Controlled Trial ◽

Patient Education ◽

Cognitive Behavioural Therapy ◽

Controlled Trial ◽

Behavioural Therapy ◽

Group Differences ◽

Post Intervention ◽

Cognitive Behavioural ◽

Randomised Controlled

IntroductionInsomnia is highly prevalent in outpatients receiving treatment for mental disorders. Cognitive–behavioural therapy for insomnia (CBT-I) is a recommended first-line intervention. However, access is limited and most patients with insomnia who are receiving mental healthcare services are treated using medication. This multicentre randomised controlled trial (RCT) examines additional benefits of a digital adaptation of CBT-I (dCBT-I), compared with an online control intervention of patient education about insomnia (PE), in individuals referred to secondary mental health clinics.Methods and analysisA parallel group, superiority RCT with a target sample of 800 participants recruited from treatment waiting lists at Norwegian psychiatric services. Individuals awaiting treatment will receive an invitation to the RCT, with potential participants undertaking online screening and consent procedures. Eligible outpatients will be randomised to dCBT-I or PE in a 1:1 ratio. Assessments will be performed at baseline, 9 weeks after completion of baseline assessments (post-intervention assessment), 33 weeks after baseline (6 months after the post-intervention assessment) and 61 weeks after baseline (12 months after the post-intervention assessment). The primary outcome is between-group difference in insomnia severity 9 weeks after baseline. Secondary outcomes include between-group differences in levels of psychopathology, and measures of health and functioning 9 weeks after baseline. Additionally, we will test between-group differences at 6-month and 12-month follow-up, and examine any negative effects of the intervention, any changes in mental health resource use, and/or in functioning and prescription of medications across the duration of the study. Other exploratory analyses are planned.Ethics and disseminationThe study protocol has been approved by the Regional Committee for Medical and Health Research Ethics in Norway (Ref: 125068). Findings from the RCT will be disseminated via peer-reviewed publications, conference presentations, and advocacy and stakeholder groups. Exploratory analyses, including potential mediators and moderators, will be reported separately from main outcomes.Trial registration numberClinicalTrials.gov Registry (NCT04621643); Pre-results.

Download Full-text